United States
team size
5 - 9
industry / tags
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
United States
HQ address
20 W 125 St, New York, 10027, USA
Allovate's product platform is AllerDent™, an improved and patient-friendly mode of immunotherapy (IT). IT is the only disease-modifying treatment that can address the underlying causes for the US's 60M allergy sufferers. A number of issues conspire to limit IT effectiveness, particularly compliance. AllerDent seamlessly integrates patients’ daily IT administration with the ritual of daily dental care (tooth brushing), a habitual behavior.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats